Press Releases

  • May. 2021
    Leukocare appoints Dr. Georg Dönges as Chief Financial Officer
  • Mar. 2021
    Leukocare and Formycon cooperate in the development of high-quality biopharmaceuticals
  • Mar. 2021
    Rentschler Biopharma and Leukocare extend service offering with joint U.S. site
  • Mar. 2021
    Leukocare and Malvern collaborate on stabilization and formulation development of COVID-19 vaccines
  • Feb. 2021
    Leukocare appoints Professor Ulrike Protzer as member to the Scientific Advisory Board
  • Jan. 2021
    Leukocare starts operations in the US and opens development laboratories and offices in Boston Metropolitan Area
  • Oct. 2020
    Leukocare announces formation of Scientific Advisory Board
  • Jun. 2020
    Europas Hotspot der Corona- Bekämpfung
  • Apr. 2020
    ReiThera, LEUKOCARE and Univercells announce pan-European consortium for the fast-track development of a single-dose adenovirus-based COVID-19 vaccine
  • Apr. 2020
    Coronavirus (COVID-19) statement LEUKOCARE has implemented and executes a Business Continuity Plan (BCP) - We remain fully operational for our clients